Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healthbanks Biotech Co LtdfiledCriticalHealthbanks Biotech Co Ltd
Priority to TW94147192ApriorityCriticalpatent/TWI358302B/en
Publication of TW200724155ApublicationCriticalpatent/TW200724155A/en
Application grantedgrantedCritical
Publication of TWI358302BpublicationCriticalpatent/TWI358302B/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
A fusion protein for inhibiting or preventing HPV infection diseases is disclosed, which comprises a peptide sequence of human papillomavirus type 16, a peptide sequence of binding and translocation, and a peptide within carboxyl terminal fragment. The present invention further comprising a composition of antibody, which conjugates to a fragment of E7 peptide or E6 peptide, wherein the nucleotide sequence of E7 peptide is shown as SEQ. ID. NO. 1, and the nucleotide sequence of E6 peptide is shown as SEQ. ID. NO.3.
TW94147192A2005-12-292005-12-29Fusion proteins for inhibiting or preventing hpv i
TWI358302B
(en)